Allianz Biotechnologie A EUR/ DE0008481862 /
| NAV2024-04-22 | Chg.-0.5000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 193.6700EUR | -0.26% | paying dividend | Equity | Allianz Gl.Investors ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-04-23 | Public WebStation Live Factsheet | 2024 | English | - |
| 2023-11-29 | PRIIP Key Information Document | 2023 | English | 300.42 KB |
| 2023-11-29 | PRIIP Key Information Document | 2023 | German | 264.48 KB |
| 2023-09-29 | Prospectus | 2023 | German | 560.09 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 127.19 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 115.13 KB |
| 2022-12-31 | Account statment | 2022 | English | 185.10 KB |
| 2022-12-31 | Account statment | 2022 | German | 173.02 KB |
| 2022-09-13 | Key Investor Information | 2022 | English | 77.21 KB |
| 2022-09-13 | Key Investor Information | 2022 | German | 77.64 KB |
| 2022-07-25 | Prospectus | 2022 | English | 650.16 KB |
